DC 5279Musculoskeletal38 CFR § 4.71aLast verified: APR 8, 2026

Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral — VA Rating Criteria (38 CFR DC 5279)

The VA rates Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral under 38 CFR 38 CFR § 4.71a, Diagnostic Code 5279, from 10% to 10% based on the frequency and functional severity of symptoms. The maximum 10% rating requires Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral. Related conditions in the Musculoskeletal body system share this rating framework.

What are the VA rating criteria for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?

10%Disability Rating

Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral

Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral
— 38 CFR 38 CFR § 4.71a, Diagnostic Code 5279 (10% tier)

Common Questions About Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral VA Ratings

What is the VA disability rating for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?

The VA rates Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral under Diagnostic Code 5279 at the following tiers: 10%. The minimum 10% rating requires: Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral. The maximum 10% rating requires: Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral.

What is Diagnostic Code 5279?

Diagnostic Code 5279 is the VA rating identifier for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral within 38 CFR 38 CFR § 4.71a. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.

What is the highest rating for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?

The highest schedular rating for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral under DC 5279 is 10%. This tier requires: Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral. Veterans who cannot secure substantially gainful employment due to Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.

What 38 CFR section governs Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral ratings?

Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral is rated under 38 CFR 38 CFR § 4.71a, Diagnostic Code 5279. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.

Which conditions are commonly secondary to Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?

Secondary conditions caused or aggravated by Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.

What evidence do I need to establish service connection for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral?

Service connection for Metatarsalgia, anterior (Morton's disease), unilateral, or bilateral requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.

Get a Personalized Rating Analysis

VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.

Discover Your Benefits